Analytics, BioStatistics, and Machine Learning Module
- Institution
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- Principal investigator
- Marlene Behrmann
- Funding
- $71K
- Duration
- 1997–2029
Moonbase score
Still being scored
Abstract
SUMMARY – ANALYTICS, BIOSTATISTICS, AND MACHINE LEARNING MODULE The Analytics, Biostatistics, and Machine Learning (ABML) module integrates expertise in the Departments of Ophthalmology, Pediatrics, and Biostatics in an innovative approach to create access to modern computational analysis of integrated datasets. Our participating faculty generate a tremendous amount of data from a variety of sources, including de-identified medical records, retinal imaging, tissue imaging, physiological recordings from members of our cortical vision faculty, performance-based tests, molecular data from metabolomics, microbiome, RNA-Seq, ATAC-Seq, single-cell/nuclei RNA- and ATAC-Seq, and ChIP-Seq. The ABML module will connect people generating data with module personnel who are experts in biostatistics, statistical modeling, machine learning, and deep learning methodologies. The overall goal is to provide high-level analytical guidance, accelerate and enhance research discovery, and promote new collaborations between data-generating and analytical scientists. Modular activities will also be available for the training of our students and postdocs and increasing synergistic interactions between the P30 participating faculty.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Pittsburgh at PittsburghNot yet scored
Reorganization of visual function in patients with posterior cortical research: Selectivity and plasticity
Marlene Behrmann · $327K · 2017–2026
- NIH · University of Pittsburgh at Pittsburgh64
Core E: Omics Core
Sid E O'Bryant · $3.2M · 2020–2026
- NIH · University of Pittsburgh at Pittsburgh60
Project 3: Biomarkers for DS Clinical Trials
Sid E O'Bryant · $148K · 2020–2026